Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
The role of the multidrug resistance protein MRP4/ABCC4 in vivo remains undefined. To explore this role, we generated Mrp4-deficient mice. Unexpectedly, these mice showed enhanced accumulation of the anticancer agent topotecan in brain tissue and cerebrospinal fluid (CSF). Further studies demonstrat...
Kaydedildi:
| Yayımlandı: | Mol Cell Biol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2004
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC506999/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15314169/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.24.17.7612-7621.2004 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
